Incannex Company Presentation – Presentation of Psychennex, Psychedelic Therapies Subsidiary Company

Author's Avatar
May 16, 2023

MELBOURNE, Australia, May 16, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd ( IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) is pleased to announce a company presentation which details activities of its psychedelic therapies subsidiary company, called Psychennex.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

Incannex Healthcare 5/16: Media Snippet

Incannex Contact Information:

Incannex Healthcare Limited
Mr Joel Latham
Managing Director and Chief Executive Officer
+61 409 840 786
[email protected]

Investor Relations Contact – United States
Alyssa Factor
Edison Group
+1 (860) 573 9637
[email protected]

ti?nf=ODg0MDQ1MSM1NTk4MzA0IzIyNTEzMjk=
Incannex-Healthcare.png